VEGFA and familial pancreatic carcinoma: For example, in a phase I study in patients with locally advanced pancreatic cancer, the vascular endothelial growth factor (VEGF) blocker bevacizumab displayed acceptable toxicity in combination with radiotherapy and capecitabine.